Literature DB >> 14601945

Singapore's experience of SARS.

Vernon M S Oh1, T K Lim.   

Abstract

The coronavirus that causes severe acute respiratory syndrome (SARS) is transmitted mainly via respiratory droplets. Typical presenting symptoms are akin to those of ordinary pneumonia. Young patients start with fever, chills, malaise, headache, or myalgia; cough and dyspnoea follow. Older persons and those taking corticosteroids may have neither fever nor respiratory symptoms. Exceptional suspicion is needed to identify SARS early in the illness. During an outbreak, even patients with low suspicion of SARS should be promptly isolated, and all contacts quarantined. Health workers need training in the use of appropriate barriers against droplets and other body fluids. Any fever cluster in patients or carers requires immediate action: discharges, visits, and transfers between wards and hospitals should be stopped. Halting hospital admissions and ten-day quarantine of suspected cases create wide buffer zones. To counter a possible resurgence of SARS, a system of prepared isolation and quarantine facilities is important.

Entities:  

Mesh:

Year:  2003        PMID: 14601945      PMCID: PMC4953642          DOI: 10.7861/clinmedicine.3-5-448

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

Review 1.  Collateral damage: the unforeseen effects of emergency outbreak policies.

Authors:  Sue Lim; Tom Closson; Gillian Howard; Michael Gardam
Journal:  Lancet Infect Dis       Date:  2004-11       Impact factor: 25.071

Review 2.  Evaluation of the rationale for concurrent use of N95 filtering facepiece respirators with loose-fitting powered air-purifying respirators during aerosol-generating medical procedures.

Authors:  Raymond J Roberge
Journal:  Am J Infect Control       Date:  2008-03       Impact factor: 2.918

3. 

Authors:  E Navas Elorza
Journal:  FMC       Date:  2013-04-03

Review 4.  The COVID-19 pandemic, personal protective equipment and respirator: A narrative review.

Authors:  Jennifer F Ha
Journal:  Int J Clin Pract       Date:  2020-06-28       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.